Q32 Bio, Inc. (QTTB)
8.23
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
8.24
+0.01
(+0.12%)
After-Hours: 20:00
Q32 Bio Price : 8.23 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 8.35 | 9.11 | 8.17 | 8.23 | 2.098M |
| Oct 01, 2026 | 8.36 | 8.85 | 7.75 | 8.25 | 3.088M |
| Sep 30, 2026 | 10.40 | 10.40 | 7.878 | 8.27 | 5.251M |
| Sep 29, 2026 | 9.32 | 9.665 | 9.164 | 9.53 | 918140.0 |
| Sep 28, 2026 | 9.21 | 9.445 | 8.77 | 9.23 | 1.005M |
| Sep 25, 2026 | 9.20 | 9.20 | 8.74 | 8.77 | 515625.0 |
| Sep 24, 2026 | 9.51 | 9.55 | 9.05 | 9.22 | 1.075M |
| Sep 23, 2026 | 10.58 | 10.58 | 9.50 | 9.56 | 828917.0 |
| Sep 22, 2026 | 10.60 | 10.99 | 10.53 | 10.57 | 387173.0 |
| Sep 21, 2026 | 10.57 | 10.75 | 10.30 | 10.47 | 359558.0 |
| Sep 18, 2026 | 10.84 | 10.97 | 10.46 | 10.54 | 972339.0 |
| Sep 17, 2026 | 11.14 | 11.16 | 10.69 | 10.86 | 384009.0 |
| Sep 16, 2026 | 11.17 | 11.41 | 10.87 | 10.98 | 504999.0 |
| Sep 15, 2026 | 10.77 | 11.29 | 10.51 | 11.17 | 602602.0 |
| Sep 14, 2026 | 10.96 | 11.28 | 10.63 | 10.91 | 870610.0 |
| Sep 11, 2026 | 10.82 | 11.27 | 10.45 | 11.10 | 1.824M |
| Sep 10, 2026 | 11.00 | 11.08 | 10.54 | 10.72 | 937779.0 |
| Sep 09, 2026 | 11.61 | 11.95 | 11.06 | 11.14 | 488864.0 |
| Sep 08, 2026 | 12.00 | 12.00 | 11.57 | 11.69 | 592921.0 |
| Sep 04, 2026 | 12.60 | 12.70 | 11.50 | 11.99 | 853811.0 |
| Sep 03, 2026 | 13.52 | 13.59 | 12.74 | 12.80 | 491580.0 |
| Sep 02, 2026 | 14.42 | 14.55 | 13.35 | 13.59 | 434820.0 |
| Sep 01, 2026 | 14.77 | 14.77 | 14.18 | 14.36 | 331608.0 |
| Aug 31, 2026 | 14.85 | 15.32 | 14.75 | 14.87 | 349853.0 |
| Aug 28, 2026 | 15.91 | 16.25 | 14.92 | 15.03 | 353914.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 12.26 |
| Beam Therapeutics, Inc. | 24.50 |
| Prime Medicine, Inc. | 2.98 |
| Prelude Therapeutics, Inc. | 3.67 |
| Twist Bioscience Corp. | 188.67 |
Price Related Metrics
| PE Ratio | 2.742 |
| PS Ratio | 2.269 |
| Price to Book Value | 1.845 |
| Earnings Yield | 36.47% |
| Market Cap | 195.35M |
| Operating PE Ratio | 5.682 |
| Normalized PE Ratio | 2.738 |